Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Latest Insider Confidence Score

2026Q1

45.0
Bearish

Company insider confidence (by quarter)

2014Q4 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Knoll Capital Management, LLC — 2,750,000 Aug 5, 2015
Chen Bihua 10% Owner 2,375,000 Sep 24, 2024
Cormorant Asset Management, LP 10% Owner 2,375,000 Sep 24, 2024
Cormorant Global Healthcare Master Fund, LP 10% Owner 2,375,000 Sep 24, 2024
Brake Rachael Louise — 1,400,000 Feb 15, 2023

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 2, 2026 Mar 4, 2026 Smethurst Dominic Chief Medical Officer Sell 42.5 -6,097 -6.36% ✗ $50.6K
Feb 17, 2026 Feb 18, 2026 Hodgson Ian COO Sell 47.5 -847 -1.63% ✗ $6.3K
Feb 13, 2026 Feb 18, 2026 Moran Sean F. CFO Sell 40.6 -4,701 -4.64% ✓ $36.6K
Feb 13, 2026 Feb 18, 2026 Cohen Yuval CEO Sell 33.8 -13,871 -7.37% ✓ $108K
Feb 3, 2026 Feb 4, 2026 Smethurst Dominic Chief Medical Officer Sell 46.3 -3,285 -3.31% ✗ $26.6K
Feb 3, 2026 Feb 4, 2026 Hodgson Ian COO Sell 46.3 -2,415 -4.44% ✗ $19.5K
Jan 14, 2026 Jan 16, 2026 Smethurst Dominic Chief Medical Officer Neutral 90.0 +28,365 40.06% ✗ -
Jan 14, 2026 Jan 16, 2026 Moran Sean F. CFO Neutral 90.0 +28,082 38.30% ✗ -
Jan 14, 2026 Jan 16, 2026 Cohen Yuval CEO Neutral 90.0 +50,000 36.18% ✗ -
Jan 14, 2026 Jan 16, 2026 Hodgson Ian COO Neutral 90.0 +28,365 109.19% ✗ -
Dec 11, 2025 Dec 15, 2025 Cormorant Asset Management, LP 10% Owner Sell 20.0 -30,029 -1.26% ✗ $344K
Oct 24, 2025 Oct 27, 2025 Cohen Yuval CEO Sell 26.3 -27,633 -9.09% ✓ $471.2K
Oct 24, 2025 Oct 27, 2025 Moran Sean F. CFO Sell 20.0 -12,981 -15.04% ✓ $220.9K
Oct 20, 2025 Oct 21, 2025 Altmeyer Anne Director Sell 28.8 -1,060 -14.62% ✓ $21.7K
May 30, 2025 Jun 2, 2025 Kung Winston Director Neutral 90.0 +4,800 86.24% ✗ -
May 30, 2025 Jun 2, 2025 Jenkins John Kenneth Director Sell 91.3 +2,017 71.63% ✓ $20.5K
May 30, 2025 Jun 2, 2025 Ben Yong Director Neutral 90.0 +4,800 172.48% ✗ -
May 30, 2025 Jun 2, 2025 Altmeyer Anne Director Sell 91.3 +3,408 122.46% ✓ $10.1K
May 30, 2025 Jun 2, 2025 HOLMER ALAN F Director Neutral 90.0 +4,800 82.35% ✗ -
May 30, 2025 Jun 2, 2025 Jacques Rachelle Suzanne Director Neutral 90.0 +4,800 172.48% ✗ -
Mar 18, 2025 Hodgson Ian COO Neutral 52.5 - 0.00% ✗ -
Mar 6, 2025 Mar 7, 2025 Smethurst Dominic Chief Medical Officer Sell 46.3 -6,393 -8.28% ✗ $43.3K
Feb 14, 2025 Feb 18, 2025 Moran Sean F. CFO Sell 41.3 -2,792 -3.67% ✓ $24.4K
Feb 14, 2025 Feb 18, 2025 Cohen Yuval CEO Sell 37.5 -7,134 -4.91% ✓ $62.5K
Jan 31, 2025 Feb 4, 2025 Smethurst Dominic Chief Medical Officer Neutral 90.0 +27,200 54.40% ✗ -
Jan 31, 2025 Feb 4, 2025 Moran Sean F. CFO Neutral 90.0 +27,500 56.58% ✗ -
Jan 31, 2025 Feb 4, 2025 Cohen Yuval CEO Neutral 90.0 +68,100 88.19% ✗ -
Sep 20, 2024 Sep 24, 2024 Cormorant Asset Management, LP 10% Owner Buy 100.0 +350,000 17.28% ✗ $7M
Aug 16, 2024 Aug 20, 2024 Kung Winston Director Neutral 90.0 +5,566 100.00% ✗ -
Aug 20, 2024 Kung Winston Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2024 Jun 18, 2024 Moran Sean F. CFO Sell 26.3 -18,043 -8.49% ✓ $863.8K
Jun 14, 2024 Jun 18, 2024 Cohen Yuval CEO Sell 23.8 -63,358 -8.66% ✓ $3M
Jun 14, 2024 Jun 14, 2024 HOLMER ALAN F Director Neutral 52.5 - 0.00% ✗ -
May 30, 2024 Jun 3, 2024 Jenkins John Kenneth Director Neutral 90.0 +2,783 8433.33% ✗ -
May 30, 2024 Jun 3, 2024 CATLIN AVERY W Director Neutral 90.0 +2,783 177.60% ✗ -
May 30, 2024 Jun 3, 2024 Salzmann Peter Director Neutral 90.0 +2,783 100.00% ✗ -
May 30, 2024 Jun 3, 2024 Jacques Rachelle Suzanne Director Neutral 90.0 +2,783 100.00% ✗ -
May 30, 2024 Jun 3, 2024 Ben Yong Director Neutral 90.0 +2,783 100.00% ✗ -
May 30, 2024 Jun 3, 2024 HOLMER ALAN F Director Neutral 90.0 +2,783 201.81% ✗ -
May 30, 2024 Jun 3, 2024 Altmeyer Anne Director Neutral 90.0 +2,783 100.00% ✗ -
May 16, 2024 May 20, 2024 Salzmann Peter Director Neutral 52.5 - 0.00% ✗ -
May 16, 2024 May 20, 2024 Jenkins John Kenneth Director Neutral 52.5 - 0.00% ✗ -
May 16, 2024 May 20, 2024 Jacques Rachelle Suzanne Director Neutral 52.5 - 0.00% ✗ -
May 16, 2024 May 20, 2024 HOLMER ALAN F Director Neutral 52.5 - 0.00% ✗ -
May 16, 2024 May 20, 2024 CATLIN AVERY W Director Neutral 52.5 - 0.00% ✗ -
May 16, 2024 May 20, 2024 Ben Yong Director Neutral 52.5 - 0.00% ✗ -
May 16, 2024 May 20, 2024 Altmeyer Anne Director Neutral 52.5 - 0.00% ✗ -
Apr 10, 2024 Apr 11, 2024 Moran Sean F. CFO Neutral 52.5 - 0.00% ✗ -
Mar 7, 2024 Mar 11, 2024 Cormorant Asset Management, LP 10% Owner Buy 100.0 +550,000 37.29% ✗ $23.3M
Feb 27, 2024 Feb 29, 2024 Smethurst Dominic Chief Medical Officer Neutral 90.0 +50,000 100.00% ✗ -
Feb 29, 2024 Smethurst Dominic Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Feb 12, 2024 Feb 14, 2024 Moran Sean F. CFO Neutral 90.0 +40,176 604.88% ✗ -
Feb 12, 2024 Feb 14, 2024 Cohen Yuval CEO Neutral 90.0 +73,947 707.42% ✗ -
Feb 2, 2024 Feb 6, 2024 Cormorant Asset Management, LP 10% Owner Buy 100.0 +750,000 103.45% ✗ $14.3M
Jan 26, 2024 Jan 30, 2024 HOLMER ALAN F Director Neutral 52.5 - 0.00% ✗ -
Jan 26, 2024 Jan 30, 2024 Cohen Yuval CEO Neutral 52.5 - 0.00% ✗ -
Jan 26, 2024 Jan 30, 2024 Cormorant Asset Management, LP 10% Owner Buy 100.0 +282,632 63.89% ✗ $9.1M
Jan 30, 2024 Cormorant Asset Management, LP 10% Owner Neutral 52.5 - 0.00% ✗ -
May 18, 2023 May 22, 2023 Altmeyer Anne Director Neutral 52.5 - 0.00% ✗ -
May 18, 2023 May 22, 2023 Jenkins John Kenneth Director Neutral 52.5 - 0.00% ✗ -
May 18, 2023 May 22, 2023 Jacques Rachelle Suzanne Director Neutral 52.5 - 0.00% ✗ -
May 18, 2023 May 22, 2023 Salzmann Peter Director Neutral 52.5 - 0.00% ✗ -
May 18, 2023 May 22, 2023 HOLMER ALAN F Director Neutral 52.5 - 0.00% ✗ -
May 18, 2023 May 22, 2023 Ben Yong Director Neutral 52.5 - 0.00% ✗ -
May 18, 2023 May 22, 2023 CATLIN AVERY W Director Neutral 52.5 - 0.00% ✗ -
Mar 6, 2023 Mar 7, 2023 Ben Yong Director Neutral 52.5 - 0.00% ✗ -
Mar 7, 2023 Ben Yong Director Neutral 52.5 - 0.00% ✗ -
Feb 13, 2023 Feb 15, 2023 Brake Rachael Louise Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Feb 13, 2023 Feb 15, 2023 Millian Craig Stuart COO Neutral 52.5 - 0.00% ✗ -
Feb 13, 2023 Feb 15, 2023 Moran Sean F. CFO Neutral 52.5 - 0.00% ✗ -
Feb 13, 2023 Feb 15, 2023 Cohen Yuval CEO Neutral 52.5 - 0.00% ✗ -
Sep 26, 2022 Sep 28, 2022 Altmeyer Anne Director Neutral 52.5 - 0.00% ✗ -
Sep 28, 2022 Altmeyer Anne Director Neutral 52.5 - 0.00% ✗ -
Aug 10, 2022 Aug 12, 2022 Millian Craig Stuart COO Buy 90.0 +5,000 22.73% ✗ $1.3K
Aug 10, 2022 Aug 11, 2022 Cohen Yuval CEO Buy 82.5 +3,800 4.02% ✗ $1K
Aug 10, 2022 Aug 10, 2022 Moran Sean F. CFO Buy 90.0 +20,000 11.16% ✗ $5.2K
May 18, 2022 May 19, 2022 Jacques Rachelle Suzanne Director Neutral 52.5 - 0.00% ✗ -
May 18, 2022 May 19, 2022 HOLMER ALAN F Director Neutral 52.5 - 0.00% ✗ -
May 18, 2022 May 19, 2022 Jenkins John Kenneth Director Neutral 52.5 - 0.00% ✗ -
May 18, 2022 May 19, 2022 Salzmann Peter Director Neutral 52.5 - 0.00% ✗ -
May 18, 2022 May 19, 2022 CATLIN AVERY W Director Neutral 52.5 - 0.00% ✗ -
May 16, 2022 May 16, 2022 Moran Sean F. CFO Buy 85.0 +12,000 7.17% ✗ $3.6K
May 16, 2022 May 16, 2022 Cohen Yuval CEO Buy 90.0 +10,500 12.51% ✗ $2.6K
Mar 10, 2022 Mar 11, 2022 Millian Craig Stuart COO Buy 90.0 +10,000 83.33% ✗ $3.7K
Mar 10, 2022 Mar 10, 2022 Moran Sean F. CFO Buy 85.0 +15,000 9.85% ✗ $5.6K
Mar 9, 2022 Mar 9, 2022 Cohen Yuval CEO Buy 90.0 +8,600 11.42% ✗ $3.2K
Feb 1, 2022 Feb 2, 2022 Millian Craig Stuart COO Neutral 52.5 - 0.00% ✗ -
Feb 1, 2022 Feb 2, 2022 Cohen Yuval CEO Neutral 52.5 - 0.00% ✗ -
Feb 1, 2022 Feb 2, 2022 Brake Rachael Louise Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Feb 1, 2022 Feb 2, 2022 Moran Sean F. CFO Neutral 52.5 - 0.00% ✗ -
Dec 6, 2021 Dec 8, 2021 Brake Rachael Louise Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Dec 8, 2021 Brake Rachael Louise Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Jun 17, 2021 Jun 17, 2021 Salzmann Peter Director Neutral 52.5 - 0.00% ✗ -
Jun 17, 2021 Jun 17, 2021 Jenkins John Kenneth Director Neutral 52.5 - 0.00% ✗ -
Jun 17, 2021 Jun 17, 2021 Jacques Rachelle Suzanne Director Neutral 52.5 - 0.00% ✗ -
Jun 17, 2021 Jun 17, 2021 HOLMER ALAN F Director Neutral 52.5 - 0.00% ✗ -
Jun 17, 2021 Jun 17, 2021 CATLIN AVERY W Director Neutral 52.5 - 0.00% ✗ -
Feb 2, 2021 Feb 4, 2021 Moran Sean F. CFO Neutral 52.5 - 0.00% ✗ -
Feb 2, 2021 Feb 4, 2021 Cohen Yuval CEO Neutral 52.5 - 0.00% ✗ -
Feb 2, 2021 Feb 4, 2021 Millian Craig Stuart Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -